Christopher H Heath
Overview
Explore the profile of Christopher H Heath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
972
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coussement J, Heath C, Roberts M, Lane R, Spelman T, Smibert O, et al.
Clin Infect Dis
. 2024 Dec;
PMID: 39692570
Background: Limited data exist regarding outcomes of cryptococcosis in patients without HIV with few studies having compared outcomes of Cryptococcus gattii, versus C. neoformans, infection. Methods: We conducted a retrospective...
2.
Tio S, Chen S, Heath C, Pradhan A, Morris A, Korman T, et al.
Open Forum Infect Dis
. 2024 Nov;
11(11):ofae594.
PMID: 39494451
Background: International consensus definitions for invasive aspergillosis (IA) in research are rigorous, yet clinically significant cases are often excluded from clinical studies for not meeting proven/probable IA case definitions. To...
3.
Tan K, Boan P, Heath C
Intern Med J
. 2024 Mar;
54(3):516-517.
PMID: 38475978
No abstract available.
4.
Chang C, Harrison T, Bicanic T, Chayakulkeeree M, Sorrell T, Warris A, et al.
Lancet Infect Dis
. 2024 Feb;
24(8):e495-e512.
PMID: 38346436
Cryptococcosis is a major worldwide disseminated invasive fungal infection. Cryptococcosis, particularly in its most lethal manifestation of cryptococcal meningitis, accounts for substantial mortality and morbidity. The breadth of the clinical...
5.
Tio S, Chen S, Hamilton K, Heath C, Pradhan A, Morris A, et al.
Lancet Reg Health West Pac
. 2023 Sep;
40:100888.
PMID: 37701716
Background: New and emerging risks for invasive aspergillosis (IA) bring the need for contemporary analyses of the epidemiology and outcomes of IA, in order to improve clinical practice. Methods: The...
6.
Hall V, Sim B, Lim C, Hocking C, Teo T, Runnegar N, et al.
Lancet Reg Health West Pac
. 2023 Jun;
:100824.
PMID: 37360862
Background: The global COVID-19 pandemic disproportionately affected certain populations and its management differed between countries. This national study describes characteristics and outcomes of COVID-19 in patients with cancer in Australia....
7.
Coussement J, Heath C, Roberts M, Lane R, Spelman T, Smibert O, et al.
Clin Infect Dis
. 2023 May;
77(7):976-986.
PMID: 37235212
Background: Patients without human immunodeficiency virus (HIV) are increasingly recognized as being at risk for cryptococcosis. Knowledge of characteristics of cryptococcosis in these patients remains incomplete. Methods: We conducted a...
8.
Salmanton-Garcia J, Au W, Hoenigl M, Chai L, Badali H, Basher A, et al.
Int J Antimicrob Agents
. 2023 Jan;
61(3):106718.
PMID: 36640851
Introduction: Invasive fungal infections (IFIs) in Asia/Pacific are a particular threat to patients with malignancies, uncontrolled diabetes mellitus or undiagnosed/untreated human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV/AIDS). Adequate...
9.
Chew S, Heath C, Petursson C, Boan P, Robinson J, Italiano C, et al.
Mycoses
. 2022 Aug;
65(10):946-952.
PMID: 35923125
Background: Antifungal administration via outpatient parenteral antimicrobial therapy (OPAT) is infrequent. As patients with invasive fungal infections (IFIs) receiving OPAT are at high risk of readmissions, careful, risk-based patient selection...
10.
Harun A, Kan A, Schwabenbauer K, Gilgado F, Perdomo H, Firacative C, et al.
Front Cell Infect Microbiol
. 2022 Jan;
11:761596.
PMID: 35024355
spp. are the second most prevalent filamentous fungi after spp. recovered from cystic fibrosis (CF) patients in various regions of the world. Although invasive infection is uncommon prior to lung...